title: An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation.
abstract: The aryl hydrocarbon receptor (AHR) agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters differentiation of B cells and suppresses antibody production. A combination of whole-genome, microarray-based chromatin immunoprecipitation (ChIP-on-chip), and time course gene expression microarray analysis was performed on the mouse B-cell line CH12.LX following exposure to lipopolysaccharide (LPS) or LPS and TCDD to identify the primary and downstream transcriptional elements of B-cell differentiation that are altered by the AHR. ChIP-on-chip analysis identified 1893 regions with a significant increase in AHR binding with TCDD treatment. Transcription factor binding site analysis on the ChIP-on-chip data showed enrichment in AHR response elements. Other transcription factors showed significant coenrichment with AHR response elements. When ChIP-on-chip regions were compared with gene expression changes at the early time points, 78 genes were identified as potential direct targets of the AHR. AHR binding and expression changes were confirmed for a subset of genes in primary mouse B cells. Network analysis examining connections between the 78 potential AHR target genes and three transcription factors known to regulate B-cell differentiation indicated multiple paths for potential regulation by the AHR. Enrichment analysis on the differentially expressed genes at each time point evaluated the downstream impact of AHR-regulated gene expression changes on B-cell-related processes. AHR-mediated impairment of B-cell differentiation occurred at multiple nodes of the B-cell differentiation network and potentially through multiple mechanisms including direct cis-acting effects on key regulators of B-cell differentiation, indirect regulation of B-cell differentiation-related pathways, and transcriptional coregulation of target genes by AHR and other transcription factors.
authors.affiliation: The Hamner Institutes for Health Sciences, Research Triangle Park, North Carolina 27709, USA.
authors.forename: K Nadira
authors.initials: KN
authors.lastname: De Abrew
authors.forename: Norbert E
authors.initials: NE
authors.lastname: Kaminski
authors.forename: Russell S
authors.initials: RS
authors.lastname: Thomas
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D002454:Cell Differentiation / Q000187:drug effects / Q000276:immunology; D045744:Cell Line, Tumor; D004359:Drug Therapy, Combination; D004785:Environmental Pollutants / Q000633:toxicity; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D020869:Gene Expression Profiling; D023281:Genomics; D007166:Immunosuppressive Agents / Q000633:toxicity*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D020411:Oligonucleotide Array Sequence Analysis; D000072317:Polychlorinated Dibenzodioxins / Q000633:toxicity; D018336:Receptors, Aryl Hydrocarbon / Q000187:drug effects / Q000235:genetics* / Q000276:immunology; D013154:Spleen / Q000166:cytology
chemical_list: D004785:Environmental Pollutants; D007166:Immunosuppressive Agents; D008070:Lipopolysaccharides; D000072317:Polychlorinated Dibenzodioxins; D018336:Receptors, Aryl Hydrocarbon
references.citation: Nat Biotechnol. 2008 Nov;26(11):1293-300
references.pmid: 18978777
references.citation: J Interferon Cytokine Res. 2009 Dec;29(12):765-80
references.pmid: 19929577
references.citation: Environ Health Perspect. 2009 Jul;117(7):1139-46
references.pmid: 19654925
references.citation: J Biol Chem. 1998 Feb 27;273(9):5174-83
references.pmid: 9478971
references.citation: Chem Res Toxicol. 2006 Oct;19(10):1284-93
references.pmid: 17040097
references.citation: Mol Cell Biol. 2004 Nov;24(22):10058-71
references.pmid: 15509806
references.citation: J Biol Chem. 1992 Apr 5;267(10):6874-8
references.pmid: 1313025
references.citation: PLoS One. 2009 Aug 11;4(8):e6589
references.pmid: 19668381
references.citation: J Immunol. 2008 Apr 1;180(7):4805-15
references.pmid: 18354204
references.citation: Int J Hematol. 2003 Aug;78(2):106-13
references.pmid: 12953803
references.citation: Annu Rev Pharmacol Toxicol. 2000;40:519-61
references.pmid: 10836146
references.citation: Oncogene. 2009 Aug 13;28(32):2873-81
references.pmid: 19543322
references.citation: Immunopharmacology. 1993 Sep-Oct;26(2):105-12
references.pmid: 8282534
references.citation: Annu Rev Pharmacol Toxicol. 1982;22:517-54
references.pmid: 6282188
references.citation: J Leukoc Biol. 1996 Aug;60(2):159-66
references.pmid: 8773576
references.citation: J Pharmacol Exp Ther. 2000 Nov;295(2):705-16
references.pmid: 11046109
references.citation: J Pharmacol Exp Ther. 2004 Apr;309(1):71-8
references.pmid: 14718603
references.citation: PLoS Comput Biol. 2007 Apr 6;3(4):e63
references.pmid: 17411336
references.citation: BMC Genomics. 2006 Aug 26;7:217
references.pmid: 16934159
references.citation: Mol Cell Biol. 2002 Jul;22(13):4771-80
references.pmid: 12052884
references.citation: Oncogene. 2008 Apr 7;27(16):2276-88
references.pmid: 18391970
references.citation: Toxicol Appl Pharmacol. 2002 Jun 1;181(2):116-23
references.pmid: 12051995
references.citation: Toxicology. 1991;69(3):219-55
references.pmid: 1949050
references.citation: Nucleic Acids Res. 2003 Feb 15;31(4):e15
references.pmid: 12582260
references.citation: Biochem Pharmacol. 1996 Sep 13;52(5):771-80
references.pmid: 8765475
references.citation: Toxicol Sci. 2009 Nov;112(1):123-32
references.pmid: 19675145
references.citation: J Pharmacol Exp Ther. 2008 Aug;326(2):463-74
references.pmid: 18483191
references.citation: Toxicology. 2004 Aug 5;200(2-3):235-46
references.pmid: 15212819
references.citation: Chem Biol Interact. 2002 Sep 20;141(1-2):25-40
references.pmid: 12213383
references.citation: Semin Immunol. 2005 Oct;17(5):330-6
references.pmid: 15967678
references.citation: Mol Pharmacol. 1998 Apr;53(4):623-9
references.pmid: 9547351
references.citation: Lab Invest. 2009 Jun;89(6):695-707
references.pmid: 19333233
references.citation: Immunity. 2000 Aug;13(2):199-212
references.pmid: 10981963
references.citation: J Pharmacol Exp Ther. 1998 Dec;287(3):1113-8
references.pmid: 9864300
references.citation: Annu Rev Immunol. 2008;26:133-69
references.pmid: 18370921
references.citation: Curr Opin Immunol. 2008 Jun;20(3):259-64
references.pmid: 18554885
references.citation: Immunity. 2008 Mar;28(3):335-45
references.pmid: 18280186
references.citation: Oncogene. 2009 Oct 22;28(42):3723-34
references.pmid: 19701248
references.citation: Trends Immunol. 2003 Jun;24(6):343-9
references.pmid: 12810111
references.citation: Eur J Immunol. 1998 Mar;28(3):1040-51
references.pmid: 9541600
references.citation: J Mammary Gland Biol Neoplasia. 2006 Jan;11(1):75-87
references.pmid: 16947086
references.citation: Immunopharmacology. 1988 Nov-Dec;16(3):167-80
references.pmid: 3267010
references.citation: J Immunol. 2008 Oct 1;181(7):4590-602
references.pmid: 18802061
references.citation: J Virol. 2008 May;82(9):4343-53
references.pmid: 18287238
references.citation: Immunopharmacology. 1986 Dec;12(3):175-86
references.pmid: 3818259
references.citation: Nat Rev Immunol. 2005 Mar;5(3):230-42
references.pmid: 15738953
references.citation: Immunity. 2002 Jul;17(1):51-62
references.pmid: 12150891
references.citation: J Cell Biochem. 2007 Oct 15;102(3):560-70
references.pmid: 17668451
references.citation: Proc Natl Acad Sci U S A. 1986 Oct;83(19):7410-4
references.pmid: 2945204
references.citation: Annu Rev Immunol. 2001;19:595-621
references.pmid: 11244048
references.citation: PLoS Biol. 2008 Feb;6(2):e27
references.pmid: 18271625
references.citation: Immunity. 2006 Aug;25(2):225-36
references.pmid: 16919487
references.citation: Toxicol Sci. 2004 Feb;77(2):272-9
references.pmid: 14600275
references.citation: Circ Res. 2008 Jun 20;102(12):1558-65
references.pmid: 18515748
references.citation: J Exp Med. 2006 Jan 23;203(1):63-72
references.pmid: 16380510
references.citation: Chem Biol Interact. 2010 Mar 19;184(1-2):246-51
references.pmid: 19896476
references.citation: Eur J Immunol. 2008 Aug;38(8):2316-24
references.pmid: 18604866
references.citation: Toxicol Appl Pharmacol. 2001 Mar 15;171(3):157-64
references.pmid: 11243915
references.citation: Toxicol Sci. 2009 Apr;108(2):377-88
references.pmid: 19237549
references.citation: Mol Pharmacol. 2010 Feb;77(2):195-201
references.pmid: 19917880